---
figid: PMC6613304__jamapsychiatry-76-1026-g005
figlink: pmc/articles/PMC6613304/figure/yoi190035f5/
number: Figure 5.
caption: Nicotinic acid mononucleotide (NAMN) levels are maintained by 3 independent
  pathways (see light blue arrows). First, the Preiss-Handler pathway uses dietary
  nicotinic acid (NA) and the enzyme nicotinic acid phosphoribosyltransferase (NAPRT1)
  to generate NAMN, which is then transformed into nicotinic acid adenine dinucleotide
  (NAAD) by NAMN transferase (NMNAT) and finally into NAD+ by NAD+ synthase (NADS).
  Second, the de novo synthesis pathway of NAD+ from tryptophan occurs through the
  kynurenine pathway to produce 2-amino-3-carboxymuconate semialdehyde (ACMS). This
  metabolite is converted nonenzymatically into quinolinc acid (QUIN), which is transformed
  into NAMN by quinolinate phosphoribosyltransferase (QPRT). Third, nicotinic acid
  riboside (NAR) is converted into NAMN by nicotinamide riboside kinase (NMRK2). The
  second and third pathways converge with the Preiss-Handler pathway via NAMN. The
  NAD salvage pathway recycles the nicotinamide generated as a by-product of the enzymatic
  activities of NAD+-consuming enzymes. Nicotinamide phosphoribosyltransferase (NAMPT)
  recycles nicotinamide into nicotinamide mononucleotide (NMN). NAD+ is converted
  to nicotinamide adenine dinucleotide phosphate (NADP) by NAD+ kinase (NADK). Pathways
  are described at https://reactome.org/content/detail/R-HSA-197264 and by Verdin
  et al. ACMSD indicates aminocarboxymuconate semialdehyde decarboxylase; AMS, α-aminomuconate
  semialdehyde; NADH, reduced form of nicotinamide adenine dinucleotide; NADPH, reduced
  form of nicotinamide adenine dinucleotide phosphate; NAM, nicotinamide; NR, nicotinamide
  riboside; and TCA, tricarboxylic acid cycle.
pmcid: PMC6613304
papertitle: Association of Schizophrenia Risk With Disordered Niacin Metabolism in
  an Indian Genome-wide Association Study.
reftext: Sathish Periyasamy, et al. JAMA Psychiatry. 2019 Oct;76(10):1026-1034.
pmc_ranked_result_index: '2662'
pathway_score: 0.9011813
filename: jamapsychiatry-76-1026-g005.jpg
figtitle: Nicotinamide Adenine Dinucleotide (NAD+) Biosynthetic Pathways
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6613304__jamapsychiatry-76-1026-g005.html
  '@type': Dataset
  description: Nicotinic acid mononucleotide (NAMN) levels are maintained by 3 independent
    pathways (see light blue arrows). First, the Preiss-Handler pathway uses dietary
    nicotinic acid (NA) and the enzyme nicotinic acid phosphoribosyltransferase (NAPRT1)
    to generate NAMN, which is then transformed into nicotinic acid adenine dinucleotide
    (NAAD) by NAMN transferase (NMNAT) and finally into NAD+ by NAD+ synthase (NADS).
    Second, the de novo synthesis pathway of NAD+ from tryptophan occurs through the
    kynurenine pathway to produce 2-amino-3-carboxymuconate semialdehyde (ACMS). This
    metabolite is converted nonenzymatically into quinolinc acid (QUIN), which is
    transformed into NAMN by quinolinate phosphoribosyltransferase (QPRT). Third,
    nicotinic acid riboside (NAR) is converted into NAMN by nicotinamide riboside
    kinase (NMRK2). The second and third pathways converge with the Preiss-Handler
    pathway via NAMN. The NAD salvage pathway recycles the nicotinamide generated
    as a by-product of the enzymatic activities of NAD+-consuming enzymes. Nicotinamide
    phosphoribosyltransferase (NAMPT) recycles nicotinamide into nicotinamide mononucleotide
    (NMN). NAD+ is converted to nicotinamide adenine dinucleotide phosphate (NADP)
    by NAD+ kinase (NADK). Pathways are described at https://reactome.org/content/detail/R-HSA-197264
    and by Verdin et al. ACMSD indicates aminocarboxymuconate semialdehyde decarboxylase;
    AMS, α-aminomuconate semialdehyde; NADH, reduced form of nicotinamide adenine
    dinucleotide; NADPH, reduced form of nicotinamide adenine dinucleotide phosphate;
    NAM, nicotinamide; NR, nicotinamide riboside; and TCA, tricarboxylic acid cycle.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NAPRT
  - QPRT
  - ACMSD
  - NMNAT3
  - NMNAT1
  - NMNAT2
  - NADK
  - NMRK2
  - CPSF4
  - NAMPT
  - NMRK1
  - Kynurenine
  - Tryptophan
  - TCA
  - NADS
  - NAAD
  - NADH
  - NAD
  - NADK
  - NADP
  - NADPH
  - NAMPT
genes:
- word: NAPRT1
  symbol: NAPRT1
  source: hgnc_prev_symbol
  hgnc_symbol: NAPRT
  entrez: '93100'
- word: QPRT
  symbol: QPRT
  source: hgnc_symbol
  hgnc_symbol: QPRT
  entrez: '23475'
- word: АСMSD
  symbol: ACMSD
  source: hgnc_symbol
  hgnc_symbol: ACMSD
  entrez: '130013'
- word: NMNAT1-3
  symbol: NMNAT3
  source: hgnc_symbol
  hgnc_symbol: NMNAT3
  entrez: '349565'
- word: NMNAT1-3
  symbol: NMNAT1
  source: hgnc_symbol
  hgnc_symbol: NMNAT1
  entrez: '64802'
- word: NMNAT1-3
  symbol: NMNAT2
  source: hgnc_symbol
  hgnc_symbol: NMNAT2
  entrez: '23057'
- word: NADK
  symbol: NADK
  source: hgnc_symbol
  hgnc_symbol: NADK
  entrez: '65220'
- word: NMRK2
  symbol: NMRK2
  source: hgnc_symbol
  hgnc_symbol: NMRK2
  entrez: '27231'
- word: NMNAT1-3
  symbol: NMNAT3
  source: hgnc_symbol
  hgnc_symbol: NMNAT3
  entrez: '349565'
- word: NMNAT1-3
  symbol: NMNAT1
  source: hgnc_symbol
  hgnc_symbol: NMNAT1
  entrez: '64802'
- word: NMNAT1-3
  symbol: NMNAT2
  source: hgnc_symbol
  hgnc_symbol: NMNAT2
  entrez: '23057'
- word: NAR
  symbol: NAR
  source: hgnc_alias_symbol
  hgnc_symbol: CPSF4
  entrez: '10898'
- word: NAMPT
  symbol: NAMPT
  source: hgnc_symbol
  hgnc_symbol: NAMPT
  entrez: '10135'
- word: NMRK1-2
  symbol: NMRK2
  source: hgnc_symbol
  hgnc_symbol: NMRK2
  entrez: '27231'
- word: NMRK1-2
  symbol: NMRK1
  source: hgnc_symbol
  hgnc_symbol: NMRK1
  entrez: '54981'
chemicals:
- word: Kynurenine
  source: MESH
  identifier: C029366
- word: Tryptophan
  source: ''
  identifier: ''
- word: TCA
  source: MESH
  identifier: C000589078
- word: NADS
  source: MESH
  identifier: C055737
- word: NAAD
  source: MESH
  identifier: C053851
- word: NADH
  source: MESH
  identifier: D009243
- word: NAD
  source: MESH
  identifier: D009243
- word: NADK
  source: ''
  identifier: ''
- word: NADP
  source: MESH
  identifier: D009249
- word: NADPH
  source: MESH
  identifier: D009249
- word: NAMPT
  source: MESH
  identifier: C085455
diseases: []
---
